These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36545179)

  • 1. Effectiveness of Low-Dose Ketamine Infusion in Opioid Refractory Cancer Pain: A Case Report.
    Nath TS
    Cureus; 2022 Nov; 14(11):e31662. PubMed ID: 36545179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
    Amin P; Roeland E; Atayee R
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose ketamine as an adjuvant for pain control in a cancer patient: a case report.
    Patel S; Tatachar V; Singh AB; Galea J; Fattakhov E; Kaur G
    Ann Palliat Med; 2021 Jul; 10(7):8328-8333. PubMed ID: 33615800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Treatment of Opioid-Refractory Cancer Pain with Short-Course, Low-Dose Ketamine.
    Waldfogel JM; Nesbit S; Cohen SP; Dy SM
    J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):294-297. PubMed ID: 27754734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature.
    Uprety D; Baber A; Foy M
    Ann Hematol; 2014 May; 93(5):769-71. PubMed ID: 24232306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose ketamine improves pain relief in patients receiving intravenous opioids for acute pain in the emergency department: results of a randomized, double-blind, clinical trial.
    Beaudoin FL; Lin C; Guan W; Merchant RC
    Acad Emerg Med; 2014 Nov; 21(11):1193-202. PubMed ID: 25377395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of a multiday (10-14 days) subanesthetic dose IV ketamine infusion in the treatment of refractory chronic pain.
    Chebini A; Marzoughi S; Randhawa J; Guh D; Wiseman S; Fedoroff I; Ong M
    Pain Manag; 2022 Apr; 12(3):337-346. PubMed ID: 34528840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
    Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents.
    Finkel JC; Pestieau SR; Quezado ZM
    J Pain; 2007 Jun; 8(6):515-21. PubMed ID: 17434801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Dose Ketamine Infusion as Adjuvant Therapy during an Acute Pain Crisis in Pediatric Patients.
    Li C; Doellner C; Leis A; Marinkovic A; Gibbons K; Wagner D
    J Pain Palliat Care Pharmacother; 2021 Mar; 35(1):31-37. PubMed ID: 33793372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic Effect of Intraoperative Intravenous S-Ketamine in Opioid-Naïve Patients After Major Lumbar Fusion Surgery Is Temporary and Not Dose-Dependent: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Brinck ECV; Maisniemi K; Kankare J; Tielinen L; Tarkkila P; Kontinen VK
    Anesth Analg; 2021 Jan; 132(1):69-79. PubMed ID: 32167978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient.
    Grande LA; O'Donnell BR; Fitzgibbon DR; Terman GW
    Anesth Analg; 2008 Oct; 107(4):1380-3. PubMed ID: 18806055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of ketamine in the management of refractory cancer pain in a palliative care unit.
    Cheung KWA; Chan PC; Lo SH
    Ann Palliat Med; 2020 Nov; 9(6):4478-4489. PubMed ID: 31594372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine and Cognitive Behavioral Therapy for Rapid Opioid Tapering With Sustained Opioid Abstinence: A Case Report and 1-Year Follow-up.
    Ocker AC; Shah NB; Schwenk ES; Witkowski TA; Cohen MJ; Viscusi ER
    Pain Pract; 2020 Jan; 20(1):95-100. PubMed ID: 31408575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine as an Analgesic Adjunct for Opioid-Induced Hyperalgesia in a Patient With a Sickle Cell Pain Episode.
    Martinez MR; Garmon EH; Starling GD; Sheth MA
    Ochsner J; 2022; 22(3):281-284. PubMed ID: 36189096
    [No Abstract]   [Full Text] [Related]  

  • 19. Ketamine infusion for 96 hr after thoracotomy: Effects on acute and persistent pain.
    Chumbley GM; Thompson L; Swatman JE; Urch C
    Eur J Pain; 2019 May; 23(5):985-993. PubMed ID: 30719817
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.